Half-life-extended monoclonal antibody APG777 for atopic dermatitis: Design of the phase 2 APEX study. J of Skin [Internet]. 2025 Mar. 17 [cited 2026 May 1];9(2):s550. Available from: https://skin.dermsquared.com/skin/article/view/3298